News | Left Atrial Appendage (LAA) Occluders | October 28, 2015

SentreHeart Receives CE Mark for Lariat Suture Delivery Device

Device gives European surgeons a new option for soft tissue closure, including the left atrial appendage

Sentreheart, Lariat Surgical LAA Suture Delivery Device, left atrial appendage closure, CE Mark approval, Europe

Image courtesy of SentreHeart

October 28, 2015 — SentreHeart Inc. announced that it has received CE Mark approval for the Lariat Surgical Left Atrial Appendage (LAA) Suture Delivery Device. The Lariat Surgical LAA device is a suture-based solution for soft tissue closure, including the LAA. European surgeons can now offer their patients precise, user-controlled delivery of a 50mm pre-tied suture loop through traditional open surgical procedures or through an access port as small as 5mm.

The device compliments the company’s innovative soft tissue closure technology by leveraging the Lariat’s low-profile delivery, designed to be compatible with a broad array of surgical approaches for LAA or other soft tissue closure. Features of the Lariat include an easy-to-use 50mm snare that is compatible with access as small as 5mm, a malleable shaft design for ease of use in delivery from different access locations and an integrated suture-tightening system to reduce the risk of operator variability during closure. The surgeon, while under direct visualization, can guide the snare loop over soft tissue, including the left atrial appendage, confirm its exact closure location and deploy the pre-tied suture, resulting in immediate, complete ligation without leaving any metal or clip behind.

Unlike current surgical closure solutions, including staplers and clips, the Lariat Surgical LAA device uses a common polyester suture, which may prevent any metal-to-tissue interaction. Additionally, its low-profile design will give surgeons greater control in suture placement location and is designed to be compatible with open-chest, thoracotomy or port access procedures.

Krzysztof Bartus, M.D., Ph.D., associate professor of cardiac surgery at Jagiellonian University Krakow, Poland stated, “The Lariat Surgical device is an elegant surgical closure solution, combining the best of all the current approaches into a single device. The new device enables flexibility in my approach and access to close tissue where I want, with the additional confidence that it will remain closed. These are important characteristics when closing soft tissue such as the left atrial appendage.”

For more information:

Related Content

CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Sponsored Content | Videos | Peripheral Artery Disease (PAD)| July 25, 2017
This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross,
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Sponsored Content | Videos | Cardiovascular Surgery| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Overlay Init